Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Paratroopers kill terrorist who threw rocks at Israeli citizens, soldiers near Ofra in West Bank - 2IDF destroys two-kilometer-long Gaza terror tunnel in Beit Lahiya
- 3Sources: IDF does not actually know how many ballistic missiles Iran has left
- 4The Electric Bicycle Americans Can Confide in 2024
- 5Manual for Tracking down Spending plan Agreeable Travel Objections
- How Seniors Can Use Refunds and Motivators to Purchase a Hyundai Ioniq EV
- RFK Jr.'s vaccine panel delays hepatitis B shot vote after chaotic meeting
- Dominating the Mastercard Endorsement Cycle: Six Fundamental Stages
- Understanding Successful Compromise Standards to Cultivate Agreeable Connections
- China bans storing cremated remains in empty 'bone ash apartments'
- The Drone Video of the Year is stunning – you've not seen Namibia like this
- Passenger Missing After Going Overboard Disney Cruise Ship
- Israeli lawmakers pass bill reviving death penalty for terrorists
- Discovering a true sense of harmony: Contemplation and Care Practices
